Fusidic acid

From Wikipedia, the free encyclopedia

Fusidic acid
Systematic (IUPAC) name
2-(16-acetyloxy-3,11-dihydroxy-4,8,10,14- tetramethyl- 2,3,4, 5,6,7, 9,11,12, 13,15,16- dodecahydro- 1H-cyclopenta [a]phenanthren-17-ylidene) -6-methyl- hept-5-enoic acid
Identifiers
CAS number 6990-06-3
ATC code J01XC01
PubChem 3000226
Chemical data
Formula C31H48O6 
Mol. mass 516.709
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Fusidic acid is an antibiotic used particularly for eye and skin infections.

It works by interfering with bacterial protein synthesis, specifically by preventing the translocation of the elongation factor G (EF-G) from the ribosome, although it works only on gram-positive bacteria such as Staphylococcus aureus, Streptococcus and Corynebacterium minutissimum. Therefore it is bacteriostatic.

It was first isolated in 1962 from the fungus Fusidium coccineum, and later from Mucor ramannianus and Isaria kogana.

It is delivered as an ointment, a cream, eye drops or in tablet form.

[edit] Brand names

  • Fusidin (of Leo in Canada)
  • Fucidin (of Leo in UK)
  • Fucithalmic (of Leo in UK and Denmark)
  • Fucicort
  • Fucibet

[edit] References

In other languages